Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder

摘要

The present invention relates to the use of at least one of melatonin, a melatonin analogue, or a pharmaceutically acceptable salt thereof in the treatment of attention deficit hyperactive disorder (ADHD). Melatonin or its analogue may be used alone or in combination with one or more other active ingredients, and is preferably formulated as a composition for controlled release.